{"entity":{"type":"insider","cik":"0001815366","url":"/insider/0001815366","json_url":"/insider/0001815366.json","name":"Zinda Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":13,"first":"2020-12-18","last":"2025-03-14","span_basis":"filed_date"},"name_variants":[{"name":"Zinda Michael","source":"filing","n_filings":13,"first_seen":"2020-12-18","last_seen":"2025-03-14"}],"transactions":[{"id":4175279,"accession":"0001415889-25-008107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-008107","line_url":"/filing/0001415889-25-008107#line-1","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5611.0,"shares_display":"5,611","price_per_share":1.14,"price_display":"1.14","price_state":"stated","total_value":6396.54,"total_display":"6,396.54","total_whole":"6,397","shares_owned_after":80297.0,"shares_owned_after_display":"80,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-12","filed_date":"2025-03-14","scope":"insider"},{"id":2862725,"accession":"0001415889-24-009625","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-009625","line_url":"/filing/0001415889-24-009625#line-2","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":410.0,"shares_display":"410","price_per_share":4.66,"price_display":"4.66","price_state":"stated","total_value":1910.6,"total_display":"1,910.60","total_whole":"1,911","shares_owned_after":71908.0,"shares_owned_after_display":"71,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-01","scope":"insider"},{"id":2862721,"accession":"0001415889-24-009625","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009625","line_url":"/filing/0001415889-24-009625#line-1","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":450.0,"shares_display":"450","price_per_share":4.64,"price_display":"4.64","price_state":"stated","total_value":2088.0,"total_display":"2,088.00","total_whole":"2,088","shares_owned_after":72318.0,"shares_owned_after_display":"72,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-28","filed_date":"2024-04-01","scope":"insider"},{"id":2899235,"accession":"0001415889-24-009253","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-009253","line_url":"/filing/0001415889-24-009253#line-3","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":450.0,"shares_display":"450","price_per_share":4.62,"price_display":"4.62","price_state":"stated","total_value":2079.0,"total_display":"2,079.00","total_whole":"2,079","shares_owned_after":72768.0,"shares_owned_after_display":"72,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-27","scope":"insider"},{"id":2899229,"accession":"0001415889-24-009253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-009253","line_url":"/filing/0001415889-24-009253#line-2","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":450.0,"shares_display":"450","price_per_share":4.61,"price_display":"4.61","price_state":"stated","total_value":2074.5,"total_display":"2,074.50","total_whole":"2,075","shares_owned_after":73218.0,"shares_owned_after_display":"73,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-26","filed_date":"2024-03-27","scope":"insider"},{"id":2899226,"accession":"0001415889-24-009253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009253","line_url":"/filing/0001415889-24-009253#line-1","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","role_mark":"O","role_mark_label":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":450.0,"shares_display":"450","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":2151.0,"total_display":"2,151.00","total_whole":"2,151","shares_owned_after":73668.0,"shares_owned_after_display":"73,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-25","filed_date":"2024-03-27","scope":"insider"},{"id":8022663,"accession":"0001209191-23-035858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-035858","line_url":"/filing/0001209191-23-035858#line-2","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2869.0,"shares_display":"2,869","price_per_share":12.02,"price_display":"12.02","price_state":"stated","total_value":34485.38,"total_display":"34,485.38","total_whole":"34,485","shares_owned_after":60118.0,"shares_owned_after_display":"60,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-09","scope":"insider"},{"id":8022660,"accession":"0001209191-23-035858","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035858","line_url":"/filing/0001209191-23-035858#line-1","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6404.0,"shares_display":"6,404","price_per_share":12.03,"price_display":"12.03","price_state":"stated","total_value":77040.12,"total_display":"77,040.12","total_whole":"77,040","shares_owned_after":62987.0,"shares_owned_after_display":"62,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-09","scope":"insider"},{"id":8629248,"accession":"0001209191-23-035135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-035135","line_url":"/filing/0001209191-23-035135#line-1","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Scientific Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":12.04,"price_display":"12.04","price_state":"stated","total_value":14448.0,"total_display":"14,448.00","total_whole":"14,448","shares_owned_after":69391.0,"shares_owned_after_display":"69,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-07","scope":"insider"},{"id":6144196,"accession":"0001209191-22-019202","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-019202","line_url":"/filing/0001209191-22-019202#line-1","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Science Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":533.0,"shares_display":"533","price_per_share":11.3,"price_display":"11.30","price_state":"stated","total_value":6022.9,"total_display":"6,022.90","total_whole":"6,023","shares_owned_after":46041.0,"shares_owned_after_display":"46,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-15","filed_date":"2022-03-16","scope":"insider"},{"id":5114244,"accession":"0001209191-21-065302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-065302","line_url":"/filing/0001209191-21-065302","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Science Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":27.33065,"price_display":"27.33","price_state":"stated","total_value":546613.0,"total_display":"546,613.00","total_whole":"546,613","shares_owned_after":4433.0,"shares_owned_after_display":"4,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-17","scope":"insider","n_lines":2},{"id":4896253,"accession":"0001209191-21-052772","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-052772","line_url":"/filing/0001209191-21-052772","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":33.9924,"price_display":"33.99","price_state":"stated","total_value":509886.0,"total_display":"509,886.00","total_whole":"509,886","shares_owned_after":21233.0,"shares_owned_after_display":"21,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-20","scope":"insider","n_lines":2},{"id":5425394,"accession":"0001209191-21-033670","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-033670","line_url":"/filing/0001209191-21-033670","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":32.71402390666667,"price_display":"32.71","price_state":"stated","total_value":490710.3586,"total_display":"490,710.36","total_whole":"490,710","shares_owned_after":37362.0,"shares_owned_after_display":"37,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-18","scope":"insider","n_lines":3},{"id":2840922,"accession":"0001209191-20-065544","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-065544","line_url":"/filing/0001209191-20-065544","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19696.0,"shares_display":"19,696","price_per_share":33.666562246141346,"price_display":"33.67","price_state":"stated","total_value":663096.61,"total_display":"663,096.61","total_whole":"663,097","shares_owned_after":55690.0,"shares_owned_after_display":"55,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-29","filed_date":"2020-12-30","scope":"insider","n_lines":3},{"id":2840913,"accession":"0001209191-20-065544","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-065544","line_url":"/filing/0001209191-20-065544","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15048.0,"shares_display":"15,048","price_per_share":34.2477033492823,"price_display":"34.25","price_state":"stated","total_value":515359.44,"total_display":"515,359.44","total_whole":"515,359","shares_owned_after":70551.0,"shares_owned_after_display":"70,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-28","filed_date":"2020-12-30","scope":"insider","n_lines":2},{"id":3048606,"accession":"0001209191-20-065185","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-20-065185","line_url":"/filing/0001209191-20-065185#line-11","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":432.0,"shares_display":"432","price_per_share":33.14,"price_display":"33.14","price_state":"stated","total_value":14316.48,"total_display":"14,316.48","total_whole":"14,316","shares_owned_after":85229.0,"shares_owned_after_display":"85,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-24","filed_date":"2020-12-28","scope":"insider"},{"id":3048601,"accession":"0001209191-20-065185","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-20-065185","line_url":"/filing/0001209191-20-065185","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16235.0,"shares_display":"16,235","price_per_share":33.65675515860794,"price_display":"33.66","price_state":"stated","total_value":546417.42,"total_display":"546,417.42","total_whole":"546,417","shares_owned_after":88908.0,"shares_owned_after_display":"88,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-23","filed_date":"2020-12-28","scope":"insider","n_lines":2},{"id":3048587,"accession":"0001209191-20-065185","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-065185","line_url":"/filing/0001209191-20-065185","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41312.0,"shares_display":"41,312","price_per_share":33.384972889233154,"price_display":"33.38","price_state":"stated","total_value":1379200.0,"total_display":"1,379,200.00","total_whole":"1,379,200","shares_owned_after":85229.0,"shares_owned_after_display":"85,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-22","filed_date":"2020-12-28","scope":"insider","n_lines":2},{"id":2692042,"accession":"0001209191-20-064840","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-064840","line_url":"/filing/0001209191-20-064840#line-2","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":33.08,"price_display":"33.08","price_state":"stated","total_value":1323200.0,"total_display":"1,323,200.00","total_whole":"1,323,200","shares_owned_after":85229.0,"shares_owned_after_display":"85,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-22","scope":"insider"},{"id":2346958,"accession":"0001209191-20-064574","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-064574","line_url":"/filing/0001209191-20-064574","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8321.0,"shares_display":"8,321","price_per_share":34.60225814205023,"price_display":"34.60","price_state":"stated","total_value":287925.39,"total_display":"287,925.39","total_whole":"287,925","shares_owned_after":85429.0,"shares_owned_after_display":"85,429","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-18","scope":"insider","n_lines":2},{"id":2346944,"accession":"0001209191-20-064574","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-064574","line_url":"/filing/0001209191-20-064574","is_derivative":false,"issuer_cik":"0001808158","issuer_name":"Repare Therapeutics Inc.","issuer_ticker":"RPTX","issuer_name_source":null,"issuer_url":"/issuer/0001808158","owner_cik":"0001815366","owner_name":"Zinda Michael","owner_display_name":"Zinda Michael","owner_url":"/insider/0001815366","role":"Officer (EVP, Chief Science Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Science Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Science Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8956.0,"shares_display":"8,956","price_per_share":35.25760160786065,"price_display":"35.26","price_state":"stated","total_value":315767.08,"total_display":"315,767.08","total_whole":"315,767","shares_owned_after":86163.0,"shares_owned_after_display":"86,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-18","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001808158","name":"Repare Therapeutics Inc.","url":"/issuer/0001808158","role":"Officer (EVP, CHIEF SCIENTIFIC OFFICER)","n_filings":13,"first_seen":"2020-12-18","last_seen":"2025-03-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001815366","retrieved_at":"2026-08-22T22:50:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}